5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 49.96▼ | 49.96▼ | 49.96▼ | 49.74▼ | 49.78▼ |
MA10 | 49.94▼ | 49.94▼ | 49.93▼ | 49.82▼ | 49.77▼ |
MA20 | 49.87▼ | 49.86▼ | 49.84▼ | 49.83▼ | 49.52▲ |
MA50 | 49.79▼ | 49.78▲ | 49.74▲ | 49.78▼ | N/A |
MA100 | 49.59▲ | 49.66▲ | 49.74▲ | 49.51▲ | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.004▼ | -0.004▼ | -0.026▼ | N/A |
RSI | 44.413▼ | 45.486▼ | 46.629▼ | 46.175▼ | 45.034▼ |
STOCH | 75.206 | 76.007 | 77.737 | 23.471 | 57.031 |
WILL %R | -100.000▼ | -100.000▼ | -89.655▼ | -72.582 | -32.675 |
CCI | -163.814▼ | -138.535▼ | -106.702▼ | -64.778 | 17.564 |
Thursday, July 17, 2025 06:31 AM
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) is a leading developer of autologous adult stem cell therapies for debilitating neurodegenerative diseases.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 49.77 | 49.77 | 49.738 | 49.74 | 4,700 |
07/08/25 | 49.68 | 49.705 | 49.68 | 49.705 | 763 |
06/08/25 | 49.76 | 49.765 | 49.76 | 49.765 | 322 |
05/08/25 | 49.75 | 49.79 | 49.73 | 49.74 | 1,100 |
04/08/25 | 49.759 | 49.79 | 49.73 | 49.76 | 3,400 |
01/08/25 | 49.71 | 49.71 | 49.63 | 49.635 | 2,500 |
31/07/25 | 50.0312 | 50.0312 | 49.98 | 49.99 | 1,888 |
30/07/25 | 49.97 | 49.98 | 49.95 | 49.96 | 3,700 |
29/07/25 | 49.979 | 49.979 | 49.94 | 49.95 | 3,400 |
28/07/25 | 49.96 | 49.96 | 49.92 | 49.93 | 2,692 |
|
|
||||
|
|
||||
|
|